Optimizing adjuvant treatment in HR+/HER2- early breast cancer

(1:56)

Optimizing adjuvant therapy: chemotherapy necessity in HR-positive breast cancer

(1:19)

Dr. Perez Discusses Optimizing Adjuvant Therapy

(1:33)

Optimizing Adjuvant Treatment of Early Breast Cancer: Where Are We Today?

(27:11)

Dr. Muss on Optimizing Adjuvant Treatment for Older Breast Cancer Patients

(59)

Optimizing Adjuvant Therapy ThroughGenomics Dr. Harold Burstein Day 1

(41:23)

Melanoma: Optimizing Selection of Adjuvant Therapy

(5:16)

Optimizing adjuvant endocrine therapy for early Breast Cancer

(30:20)

Optimizing the diagnostic process for MDS: advances in genetics and digital tools

(1:30)

Optimizing neoadjuvant and adjuvant therapy for patients undergoing CRS and HIPEC

(38)

Adjuvant Therapy | 2023 KU Breast Cancer Year in Review Conference

(30:22)

Neoadjuvant and Adjuvant Chemotherapy in Bladder Cancer

(20:29)

Optimizing the Approach to Adjuvant Therapy for Resected Melanoma

(5:59)

Optimizing Adjuvant Therapy in Early Stage Breast Cancer

(2:11:21)

Optimizing Treatment of Advanced Pancreatic Cancer

(5:12)

Adherence to adjuvant immunotherapy and TKIs in resected in NSCLC

(52)

Part 6 - Neo-adjuvant therapy, residual disease, and optimizing adjuvant therapy - Dr. B.K.Smruti

(18:33)

Optimizing Therapy in HER2+ Disease with Dr. Hope S. Rugo

(49:25)

New \u0026 Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Mahtani \u0026 Dr. Schwartzberg

(1:7:43)

New \u0026 Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Irene and Dr. Vogel

(52:21)